NM_138448.4:c.58+4857C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_138448.4(ACYP2):c.58+4857C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 152,228 control chromosomes in the GnomAD database, including 979 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.11 ( 979 hom., cov: 32)
Consequence
ACYP2
NM_138448.4 intron
NM_138448.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.84
Publications
19 publications found
Genes affected
ACYP2 (HGNC:180): (acylphosphatase 2) Acylphosphatase can hydrolyze the phosphoenzyme intermediate of different membrane pumps, particularly the Ca2+/Mg2+-ATPase from sarcoplasmic reticulum of skeletal muscle. Two isoenzymes have been isolated, called muscle acylphosphatase and erythrocyte acylphosphatase on the basis of their tissue localization. This gene encodes the muscle-type isoform (MT). An increase of the MT isoform is associated with muscle differentiation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACYP2 | NM_138448.4 | c.58+4857C>T | intron_variant | Intron 1 of 3 | ENST00000394666.9 | NP_612457.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACYP2 | ENST00000394666.9 | c.58+4857C>T | intron_variant | Intron 1 of 3 | 1 | NM_138448.4 | ENSP00000378161.3 |
Frequencies
GnomAD3 genomes AF: 0.110 AC: 16785AN: 152110Hom.: 977 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
16785
AN:
152110
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.110 AC: 16801AN: 152228Hom.: 979 Cov.: 32 AF XY: 0.109 AC XY: 8101AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
16801
AN:
152228
Hom.:
Cov.:
32
AF XY:
AC XY:
8101
AN XY:
74438
show subpopulations
African (AFR)
AF:
AC:
3856
AN:
41532
American (AMR)
AF:
AC:
1684
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
508
AN:
3472
East Asian (EAS)
AF:
AC:
14
AN:
5182
South Asian (SAS)
AF:
AC:
329
AN:
4828
European-Finnish (FIN)
AF:
AC:
1099
AN:
10588
Middle Eastern (MID)
AF:
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8891
AN:
68000
Other (OTH)
AF:
AC:
210
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
779
1558
2337
3116
3895
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
151
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.